Catherine Newcomb
First Turn Management, Llc
Assets Managed
$895.099M
Holdings
33
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
2.28%(2Q avg: 16.85%)
Sustained Growth
4 quarters
Portfolio positions
This chart displays the top 10 holdings in First Turn Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 33 positions.
Assets under management
The assets under management (AUM) of First Turn Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 895.099M in assets, with a quarterly growth rate of 2.28% and a 2-quarter average growth rate of 16.85%. The portfolio is managed by Catherine Newcomb, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
UTHR United Therapeutics Corp
| 6.94% | $62.1M 104,726 shares@ $592.98 avg price | Increased 64.72% |
ABVX Abivax Sa-adr
| 5.8% | $51.875M 465,869 shares@ $111.35 avg price | Increased 22.21% |
BBIO Bridgebio Pharma Inc
| 5.78% | $51.664M 695,718 shares@ $74.27 avg price | Increased 16.84% |
XENE Xenon Pharmaceuticals Inc
| 5.12% | $45.755M 786,844 shares@ $58.16 avg price | Decreased -1.61% |
RVMD Revolution Medicines Inc
| 5.09% | $45.55M 468,376 shares@ $97.25 avg price | Decreased -26.63% |
APGE Apogee Therapeutics Inc
| 4.84% | $43.244M 513,770 shares@ $84.18 avg price | Increased 8.2% |
INSM Insmed Inc
| 4.54% | $40.631M 248,475 shares@ $163.52 avg price | Decreased -5.98% |
NUVL Nuvalent Inc-a
| 4.24% | $37.942M 370,344 shares@ $102.46 avg price | Increased 0.45% |
MIRM Mirum Pharmaceuticals Inc
| 4.14% | $36.995M 400,464 shares@ $92.38 avg price | Decreased -16.84% |
COGT Cogent Biosciences Inc
| 4.08% | $36.463M 947,339 shares@ $38.49 avg price | Increased 14.93% |
1-10 of 33